Glenn S. Van Aller

5.1k total citations
14 papers, 882 citations indexed

About

Glenn S. Van Aller is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, Glenn S. Van Aller has authored 14 papers receiving a total of 882 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Oncology and 2 papers in Infectious Diseases. Recurrent topics in Glenn S. Van Aller's work include Peptidase Inhibition and Analysis (5 papers), Epigenetics and DNA Methylation (4 papers) and Cancer-related gene regulation (4 papers). Glenn S. Van Aller is often cited by papers focused on Peptidase Inhibition and Analysis (5 papers), Epigenetics and DNA Methylation (4 papers) and Cancer-related gene regulation (4 papers). Glenn S. Van Aller collaborates with scholars based in United States, Netherlands and Hungary. Glenn S. Van Aller's co-authors include Peter J. Tummino, Ryan G. Kruger, Nicolas Reynoird, Olena Barbash, Michael J. Huddleston, Benjamin A. Garcia, Shichong Liu, Julien Sage, Or Gozani and Dashyant Dhanak and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Biochemistry.

In The Last Decade

Glenn S. Van Aller

14 papers receiving 865 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Glenn S. Van Aller United States 10 627 116 85 83 79 14 882
S.H. Olesen United States 13 738 1.2× 231 2.0× 79 0.9× 79 1.0× 50 0.6× 15 1000
Heather M. Dunstan United States 8 575 0.9× 123 1.1× 67 0.8× 95 1.1× 42 0.5× 10 855
Sina Sareth United States 8 621 1.0× 146 1.3× 68 0.8× 45 0.5× 45 0.6× 9 844
Stéphane Vispé France 16 952 1.5× 243 2.1× 102 1.2× 139 1.7× 56 0.7× 23 1.1k
Yuhong Lü China 13 435 0.7× 207 1.8× 54 0.6× 161 1.9× 75 0.9× 25 672
Frédéric Thuaud France 13 754 1.2× 150 1.3× 202 2.4× 78 0.9× 55 0.7× 15 1.1k
Shunji Izuta Japan 15 476 0.8× 149 1.3× 97 1.1× 85 1.0× 26 0.3× 29 726
Jung-Chen Su Taiwan 17 435 0.7× 245 2.1× 67 0.8× 91 1.1× 61 0.8× 26 699
Aaron M. Sargeant United States 18 472 0.8× 130 1.1× 85 1.0× 130 1.6× 47 0.6× 30 819
Byung Hak Ha United States 17 646 1.0× 218 1.9× 57 0.7× 42 0.5× 34 0.4× 37 868

Countries citing papers authored by Glenn S. Van Aller

Since Specialization
Citations

This map shows the geographic impact of Glenn S. Van Aller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glenn S. Van Aller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glenn S. Van Aller more than expected).

Fields of papers citing papers by Glenn S. Van Aller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glenn S. Van Aller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glenn S. Van Aller. The network helps show where Glenn S. Van Aller may publish in the future.

Co-authorship network of co-authors of Glenn S. Van Aller

This figure shows the co-authorship network connecting the top 25 collaborators of Glenn S. Van Aller. A scholar is included among the top collaborators of Glenn S. Van Aller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Glenn S. Van Aller. Glenn S. Van Aller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Aller, Glenn S. Van, Alan P. Graves, P.A. Elkins, et al.. (2016). Structure-Based Design of a Novel SMYD3 Inhibitor that Bridges the SAM-and MEKK2-Binding Pockets. Structure. 24(5). 774–781. 42 indexed citations
2.
Mazur, Paweł K., Nicolas Reynoird, Purvesh Khatri, et al.. (2014). SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer. Nature. 510(7504). 283–287. 285 indexed citations
3.
Aller, Glenn S. Van, Melissa B. Pappalardi, Heidi M. Ott, et al.. (2013). Long Residence Time Inhibition of EZH2 in Activated Polycomb Repressive Complex 2. ACS Chemical Biology. 9(3). 622–629. 45 indexed citations
4.
Axten, Jeffrey M., Jesús R. Medina, Charles W. Blackledge, et al.. (2012). Acylprolinamides: A new class of peptide deformylase inhibitors with in vivo antibacterial activity. Bioorganic & Medicinal Chemistry Letters. 22(12). 4028–4032. 5 indexed citations
5.
Aller, Glenn S. Van, Nicolas Reynoird, Olena Barbash, et al.. (2012). Smyd3 regulates cancer cell phenotypes and catalyzes histone H4 lysine 5 methylation. Epigenetics. 7(4). 340–343. 140 indexed citations
6.
Auger, K R, Kimberly N. Smitheman, Susan Korenchuk, et al.. (2012). 387 The Focal Adhesion Kinase Inhibitor GSK2256098: a Potent and Selective Inhibitor for the Treatment of Cancer. European Journal of Cancer. 48. 118–118. 17 indexed citations
7.
Aller, Glenn S. Van, Wei Tang, Lin Zhao, et al.. (2011). Epigallocatechin gallate (EGCG), a major component of green tea, is a dual phosphoinositide-3-kinase/mTOR inhibitor. Biochemical and Biophysical Research Communications. 406(2). 194–199. 135 indexed citations
8.
Totoritis, Rachel D., Chaya Duraiswami, Amy Taylor, et al.. (2011). Understanding the Origins of Time-Dependent Inhibition by Polypeptide Deformylase Inhibitors. Biochemistry. 50(31). 6642–6654. 3 indexed citations
9.
Aller, Glenn S. Van, Christine Fernandes, Ruth Lehr, et al.. (2008). Characterization of PI3K class IA isoforms with regulatory subunit p55α using a scintillation proximity assay. Analytical Biochemistry. 383(2). 311–315. 9 indexed citations
10.
Huang, Jianzhong, Glenn S. Van Aller, Amy Taylor, et al.. (2006). Phylogenomic and Biochemical Characterization of ThreeLegionella pneumophilaPolypeptide Deformylases. Journal of Bacteriology. 188(14). 5249–5257. 8 indexed citations
11.
Aller, Glenn S. Van, Chantal Petit, Chad Quinn, et al.. (2004). Mechanism of Time-Dependent Inhibition of Polypeptide Deformylase by Actinonin. Biochemistry. 44(1). 253–260. 31 indexed citations
12.
DAINES, R. A., Israil Pendrak, Kelvin Sham, et al.. (2002). First X-ray Cocrystal Structure of a Bacterial FabH Condensing Enzyme and a Small Molecule Inhibitor Achieved Using Rational Design and Homology Modeling. Journal of Medicinal Chemistry. 46(1). 5–8. 62 indexed citations
13.
Khandekar, Sanjay S., Daniel R. Gentry, Glenn S. Van Aller, et al.. (2001). Identification, Substrate Specificity, and Inhibition of theStreptococcus pneumoniae β-Ketoacyl-Acyl Carrier Protein Synthase III (FabH). Journal of Biological Chemistry. 276(32). 30024–30030. 85 indexed citations
14.
Khandekar, Sanjay S., Alex K. Konstantinidis, Carol Silverman, et al.. (2000). Expression, Purification, and Crystallization of the Escherichia coli Selenomethionyl β-Ketoacyl–Acyl Carrier Protein Synthase III. Biochemical and Biophysical Research Communications. 270(1). 100–107. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026